Introduction
Thalassemia and the hemoglobinopathies are genetic disorders resulting in severe anemia. Affected patients require costly treatments, and the disorder places a major economic burden on countries where the disease is prevalent. Thalassemia is the most common single-gene hemoglobinopathy worldwide, and together with sickle cell disease, it is estimated that over 5% of the world's population are carriers [1] . Thalassemia is the most common genetic disorder in Malaysia where 3-4.5% of the Malays and Chinese are carriers [2] . Couples who are β-thalassemia carriers have a 25% risk of having a child with β-thalassemia major, a condition that requires lifelong monthly blood transfusions and expensive iron-chelation therapies for survival. In 2007, RM 40 million (USD 13 million) was allocated by the Malaysian Ministry of Health for the purchase of iron-chelation drugs. Affected children do not normally survive past their teenage years without good clinical management. The disorder is a huge burden on pediatric and hematology health services; as of May 2010, there were 4,768 registered transfusiondependent thalassemia major patients in the Malaysian Thalassemia Registry [3] . α-Thalassemia, which can result in Hb Bart's hydrops fetalis syndrome, has been reported in the Malaysian Malays and Chinese. This disorder is fatal and maternal complications include an enlarged placenta, renal failure and hypertension during pregnancy [4] . The α-hemoglobin variants, Hb Constant Spring (HBA2:c.427T>C), Hb Quong Sze (HBA2:c.377T>C) and Hb Adana (HBA2:c.179G>A) can also result in severe anemia when inherited in combination with deletional α-thalassemia.
Thalassemia and hemoglobinopathies have become a global health problem due to migration, international job opportunities and intermarriages [5] . Malaysia is a unique country because of its multiracial population. The Malays and Chinese form the majority at 65 and 26% of the 28.6 million people, respectively [6] . The indigenous groups who are descendents of the Austronesian people comprise a significant 12% of the total population [7] . Malaysia is separated into West and East Malaysia (comprising Sabah and Sarawak). The indigenous groups make up only 0.6% of the West Malaysian population but include 47.4% of Sabah's and 50% of Sarawak's population [8] . The total population of Sarawak is 2.5 million, and the majority of the indigenous groups -Iban, Bisayah, Melanau, Kenyah, Kayan, Kedayan, Murut, Punan, Kelabit, Berawan, and Penanlive in the interior of Sarawak. There is limited knowledge on the genetic defects of thalassemia in the Sarawakian indigenous groups. Data from the National Thalassemia Registry confirmed 103 thalassemia patients on hypertransfusion regime, and the Kedayan and Bisayah are so far the only indigenous groups with thalassemia.
Materials and Methods
This is a cross-sectional study on the transfusion-dependent β-thalassemia major and intermedia patients who attended the annual thalassemia review clinic in March 2012. The review clinic was held at 3 local government hospitals in Northern Sarawak (Miri, Limbang and Lawas). The objectives of the review clinic are to monitor the progress and treatment of transfusion-dependent thalassemia patients in the local hospitals in rural Sarawak.
Patient Population
The study consisted of 26 β-thalassemia major, 3 β-thalassemia intermedia and 3 HbE/β-thalassemia patients from the Miri, Limbang and Lawas Hospitals ( table 1 ). Blood samples were taken after verbal and written informed consent was obtained. The ages of the patients ranged from 7 to 32 years and consisted of 20 males and 12 females. This study was ethically approved by the Institute of Medical Research via National Medical Research Registry (NMRR-11-566-9342) in accordance with the Declaration of Helsinki.
Blood Collection and DNA Extraction
Blood was collected and stored with ice packages in a polystyrene box throughout the study. Blood tubes were transferred to a -70 ° C freezer upon arrival at the laboratory. DNA was extracted using standard procedures.
DNA Amplification of the α-Globin Gene Region
The deletions causing α-thalassemia are: -α 3.7 (NG_000006.1:
THAI (NG_ 000006.1:g.10664_44164del33501) and were characterized using multiplex-PCR [9] . Hb Adana, Hb Constant Spring and Hb Quong Sze were determined using multiplex amplification refractory mutation system [10] .
DNA Amplification of the β-Globin Gene Region
Twenty-three β-globin gene mutations that cause thalassemia in Malaysians were characterized using multiplex amplification refractory mutation system. The [11] . The Filipino β-deletion (NG_000007.3: g.66258_184734del118477) was confirmed using an in-house gap-PCR assay [12] .
Genomic Sequencing of the α-and β-Globin Genes
Genomic sequencing of the α-and β-globin genes was carried out according to the protocols adapted from Chan et al. [13] and Chebab et al. [14] . The genomic sequence of the novel mutation was analyzed for transcription-binding sites based on a similar approach reported using the TRANSFAC program [15, 16] .
Results
A total of 23 β-thalassemia mutations previously reported in Malaysians were analyzed, and 10 were detected in the 32 transfusion-dependent patients ( table 1 ) . The Filipino β-deletion was the most common defect in the patients. This deletion was confirmed in 26/28 of the β-thalassemia alleles from the indigenous groups studied; only 2 patients did not have the Filipino β-deletion and possessed the Poly A mutation instead. Homozygosity for Studies in the gene defects responsible for α-thalassemia showed a co-inheritance of Hb Adana or the single α-deletion (-α 3.7 /αα) in 5 of the patients. Genomic sequencing identified a previously unreported novel 24-bp deletion in intron 1 of the α2-globin gene (HBA2:c.95 + 5_95 + 28delGGCTCCCTCCCCTGCTCCGACCCG) in patient number 14 who is of Malay-Bugis ancestry ( table 1 ). The novel deletion was confirmed using reverse sequencing. The deletion was also confirmed by the DNA Diagnostic and Research Laboratory, KK Women's and Children's Hospital, Singapore.
Discussion
The total population in Sarawak is 2.5 million, consisting of 29% Iban, 23% Malays, 23% Chinese, 8% Bidayuh, 8% Melanau, and 6% other Sarawak Bumiputera [6] . This is the first molecular study of transfusion-dependent thalassemia in Northern Sarawak.
To date, more than 200 mutations causing β -thal assemia have been reported worldwide; however, a spectrum of common mutations are specific for each ethnic group. Results from this study show that the Chinese patients in Northern Sarawak have identical β-globin gene mutations (CD41/42, CD17, CD71/72, IVS2-654 and -29) to those of the Chinese in West Malaysia [17] . The Malaysian Chinese are emigrants from Southern China. Intermarriages of Asian Chinese with other ethnic groups are uncommon because of traditions, and this is the most probable reason for the similar spectrum of gene mutations of the Chinese patients in Northern Sarawak and the Chinese in other Asian countries.
In contrast, the Malaysian Malays are heterogenous and have ancestors from Turkey, Persia and the Middle East. Bisayah is a small indigenous group along coastal Northern Sarawak with a population of 3,500, and Kedayan possess a culture similar to the Malays. Intermarriages between the Malays and the indigenous populations in Sarawak are common, as observed in our patients with Malay-Kedayan, Malay-Bisayah or Malay-Bugis parentage. Results from this study showed an unexpected observation of homozygosity for the Filipino β-deletion in the Malays, as previous studies had shown that the Filipino β-deletion is rare in the Malays [17] . The Filipino β-deletion was reported to be highly prevalent in the Kadazandusuns in Sabah at 12.8% in the general population [11] , and in this study, the Filipino β-deletion was also the most common defect causing β-thalassemia in the Kedayan, Bisayah and Tagal patients. The presence of the Filipino β-deletion in the Malay patients in Northern Sarawak can probably be explained by intermarriages of the Malays with the indigenous groups. However, the study population was small and investigations with a larger sample number should be carried out.
The co-inheritance of α-thalassemia with transfusiondependent β-thalassemia is an important factor in producing milder forms of thalassemia major [18] . Studies showed that patients who co-inherited the 2 α-globin gene deletion showed less severe clinical outcomes [19] . The deletion of 2 α-globin genes was not detected; instead, the single α-globin gene (-α 3.7 /αα) deletion was confirmed in 3 Malay patients with Malay ancestry, which is in accordance with previous studies where -α 3.7 is common in Malaysian Malays. However, the single gene deletion in these 3 patients was not sufficient to ameliorate the clinical disease to a milder phenotype. Hb Adana was confirmed in a Chinese and a Malay-Kedayan patient. Hb Adana was previously identified in the Malays [20] and very rarely in Malaysian Chinese. Genomic sequencing of the α-globin gene confirmed a novel 24-bp deletion in intron 1 of the α2-globin gene in a MalayBugis patient. That patient was the only one in this study with Bugis ancestry. Based on bioinformatics analysis using the TRANSFAC program [15] , 2 putative transcription factor-binding sites surrounding the wild-type allele were identified; however, the mutation of HBA2:c.95 + 5_95 + 28delGGCTCCCTCCCCTGCTCCGACCCG eliminated these binding sites. The wild-type alleles were predicted to be located in a transcription factor B-cellspecific activator protein or zinc finger protein with interaction domain-binding sites. Both binding sites showed 98.8 and 100% homology to a core consensus sequence and 78.4 and 77.3% homology to a matrix consensus sequence. Hence, it can be hypothesized that the mutation of HBA2:c.95 + 5_95 + 28delGGC TC CC TC-CC CTGCTCCGACCCG may cause transcriptional alteration and produces an α2-globin gene variant with unknown significance. Hence, further research into this novel deletion and its effect on patient blood profiles will be carried out with family studies. The detection of this novel genetic variant highlights the importance of genomic sequencing in the molecular characterization of previously unstudied populations.
Molecular analysis for patient 3 showed heterozygosity for the β-globin gene mutation at CD41/42. Genomic sequencing of the α-and β-globin genes did not detect any other mutations. The patient was also diagnosed with ovalocytosis. Hereditary ovalocytosis aggravates the clinical manifestation of thalassemia and causes a more severe disorder. However, more extensive molecular investigations need to be carried out, as ovalocytosis with heterozygous CD41/42 is unlikely to cause transfusion-dependent thalassemia.
Thalassemia is a public health problem in Malaysia. This preliminary study has produced informative results in that the types of α-and β-globin gene mutations in Northern Sarawak are unique. This study also showed thalassemia to be present in the Tagal and Bugis indigenous groups, which has not been previously reported.
Prenatal diagnosis was previously unavailable to the 32 patients and their families. Interviews with the patients revealed that 19% (6/32) of the patients have siblings with thalassemia major (4 patients with 1 sibling each, 1 patient with 2 siblings and 1 patient with 3 siblings with thalassemia major). Thus, the types of α-and β-gene mutations identified in this study will allow offering genetic counseling and prenatal diagnosis to these affected families.
